Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Oct 7;23(11):1972-1976.
doi: 10.1093/ntr/ntab069.

Harm Reduction Associated with Dual Use of Cigarettes and e-Cigarettes in Black and Latino Smokers: Secondary Analyses from a Randomized Controlled e-Cigarette Switching Trial

Affiliations
Randomized Controlled Trial

Harm Reduction Associated with Dual Use of Cigarettes and e-Cigarettes in Black and Latino Smokers: Secondary Analyses from a Randomized Controlled e-Cigarette Switching Trial

Michael J Arnold et al. Nicotine Tob Res. .

Abstract

Introduction: Most adult cigarette smokers who use e-cigarettes are dual cigarette and e-cigarette (CC-EC) users, yet little is known about relative consumption of cigarettes to e-cigarettes and any associated harm reduction.

Methods: Rate of substitution from cigarettes to e-cigarettes at week 6 and change in biomarkers of exposure and potential harm were examined among dual dual cigarette and e-cigarette users [64/114 (56%); 35 Black, 29 Latino] in an e-cigarette switching randomized trial.

Results: Dual users averaged 79% substitution of cigarettes for e-cigarettes at week 6, resulting in a reduction from baseline of 70.0 ± 54.1 cigarettes per week (p < .001). Total nicotine consumption remained stable (baseline: 1160.5 ± 1042.1 pg/mL of cotinine, week 6: 1312.5 ± 1725.9 pg/mL of cotinine, p = .47), while significant reductions were seen in the potent lung carcinogen 4-(methylnitrosamino)-1-(3-pyridul)-1-butanol (NNAL) (-55.9 ± 88.6 ng/ml, p < .001), carbon monoxide (-6.3 ± 8.6 ppm, p < .001), and self-reported respiratory symptoms (-3.3 ± 8.0, p = .002). No significant changes were found in blood pressure or spirometry. Greater substitution from cigarettes to e-cigarettes was associated with larger reductions in NNAL (r = -.29, p = .02).

Conclusions: The predominant dual-use pattern was characterized by regular e-cigarette and intermittent cigarette use. Findings demonstrate the short-term harm reduction potential of this dual-use pattern in Black and Latino smokers and suggest that the greatest benefit, aside from cessation of both products, is achieved by higher substitution of e-cigarettes for cigarettes. Findings need confirmation in a larger sample with longer follow-up in dual users with greater variability in the rate of substitution.

Clinicaltrials.gov identifier: NCT03511001.

Implications: Findings suggest short-term harm reduction potential of dual cigarette-e-cigarette use for Black and Latino smokers. Results also demonstrate the heterogeneity of dual-use, with the greatest harm reduction seen in dual users with higher rates of substitution from cigarettes to e-cigarettes. Study results should be confirmed in a full clinical trial with long-term follow-up to evaluate maintenance of dual-use patterns and associated harm reduction potential over time.

PubMed Disclaimer

References

    1. Mirbolouk M, Charkhchi P, Kianoush S, et al. . Prevalence and distribution of e-cigarette use among u.s. adults: behavioral risk factor surveillance system, 2016. Ann Intern Med. 2018;169(7):429–438. - PMC - PubMed
    1. National Academies of Sciences E, Medicine. Public Health Consequences of E-Cigarettes. Washington, DC: National Academies Press; 2018. - PubMed
    1. Goniewicz ML, Smith DM, Edwards KC, et al. . Comparison of Nicotine and Toxicant exposure in users of electronic cigarettes and combustible cigarettes. JAMA Netw Open. 2018;1(8):e185937. - PMC - PubMed
    1. Baig SA, Giovenco DP. Behavioral heterogeneity among cigarette and e-cigarette dual users and associations with future tobacco use: Findings from the Population Assessment of Tobacco and Health Study. Addict Behav. 2020;104:106263. - PMC - PubMed
    1. Piper ME, Baker TB, Benowitz NL, Kobinsky KH, Jorenby DE. Dual users compared to smokers: demographics, dependence, and biomarkers. Nicotine Tob Res. 2019;21(9):1279–1284. - PMC - PubMed

Publication types

Associated data